ethinyl estradiol has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, M; Hakariya, T; Matsuya, F; Miyata, Y; Sakai, H; Shida, Y; Tsurusaki, T; Watanabe, J | 1 |
| Izumi, K | 1 |
2 other study(ies) available for ethinyl estradiol and mdv 3100
| Article | Year |
|---|---|
Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Estrogens; Ethinyl Estradiol; Humans; Japan; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Analysis; Treatment Outcome | 2018 |
Editorial Comment to Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men.
Topics: Benzamides; Ethinyl Estradiol; Humans; Male; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant | 2018 |